Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Change in Directorate

 We hereby inform that Mr. Milind Sarwate (DIN: 00109854) has completed his term of 5 (five) years as an Independent Director of the Company on September 06, 2023. Consequently, he ceased to be a Director of the Company and Chairman/ Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee with effect from the closure of business hours on September 06, 2023. The composition of the Committees, post completion of his term was intimated to the Stock Exchange(s) vide letter dated August 02, 2023 (Ref MHL/Sec&Legal/2023-24/39).
06-09-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Grandeur Peak Global Advisors, LLC
30-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Grandeur Peak Global Advisors, LLC
29-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Grandeur Peak Global Advisors, LLC
28-08-2023

Metropolis Healthcare, 10 others placed under F&O ban list on NSE for August 22; check details

 The derivative contracts in the mentioned securities have crossed 95 per cent of the market-wide position limit and have been currently put in the ban period by the stock exchange, said NSE.
21-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Please find enclosed herewith Voting results and a copy of Scrutinizer report of Annual General Meeting held on August 17, 2023.
21-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 23rd Annual General Meeting ("AGM") of Metropolis Healthcare Limited ("Company") was held today i.e. Thursday, August 17, 2023, at 04.30 pm (IST) through Video Conferencing ("VC")/ Other Audio Visual Means ("OAVM") in accordance with the circular(s) issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. In this regard, we enclose herewith the proceedings of the 23rd AGM. The meeting commenced at 04.30 pm (IST) and concluded at 05.00 pm (IST).
17-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Metropolis Healthcare Limited Has Informed The Exchange Regarding ''Disclosure Of Continuing Material Events Or Information (I.E. Ongoing Litigations) As Required Under Regulation 30(4) Of The SEBI (LODR) Regulations, 2015''

 Pursuant to Regulation 30(4)(i)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company is required to disclose any continuing event or information which becomes material as per the criteria prescribed thereunder In view of the above, the details of pending litigation filed by our Subsidiary "Metropolis Bramser Lab Services (Mtius) Ltd" is enclosed herewith.
14-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) on August 18, 2023 and the Host for the said meeting is Avendus Spark Institutional Equities. Discussions will be based on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of the Participants/Host/Company.
10-08-2023
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 In continuation to our letter bearing Reference No. MHL/Sec&Legal/2023-24/37 dated July 29, 2023, please find enclosed herewith the transcript of Q1/FY24 Conference Call, as organized by Nuvama Wealth Management held on August 03, 2023 at 09:00 a.m. (IST) wherein the financial results of the Company for the quarter ended June 30, 2023 were discussed. The same has also been uploaded on the Company''s website and can be accessed at https://www.metropolisindia.com/investors
09-08-2023
Next Page
Close

Let's Open Free Demat Account